Drug-Eluting Stent

Coronary stents with pharmaceutical coating designed to prevent restenosis and promote vessel patency. These devices are used for treatment of coronary artery disease.

Specialized stents with controlled drug delivery coatings for sustained release of active pharmaceutical ingredients. Designed to prevent restenosis and maintain vessel patency with optimized clinical performance.

A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.

Stent systems coated with antiproliferative medications to reduce restenosis rates. Available for coronary and peripheral vessel applications.

Advanced drug-eluting stent coatings that deliver pharmaceutical agents with controlled release profiles to prevent vessel restenosis. These specialty coatings combine hydrophilic polymers with active drug compounds, applied to stent surfaces to enhance biocompatibility and clinical efficacy in cardiovascular interventions.

Drug-eluting stent platforms that combine mechanical support with pharmaceutical delivery mechanisms for vascular applications. The product line includes multiple proprietary formulations and coating technologies.

A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.

Stent device coated with medication for coronary, peripheral, and cerebrovascular applications. Used to expand narrowed or blocked blood vessels while preventing restenosis.

Nitinol platform structures for drug-eluting stent systems with advanced surface coatings. Engineered to support controlled drug release while maintaining optimal hemodynamic properties.

Specialized biocompatible polymer coating for drug-eluting stent platforms enabling controlled pharmaceutical release. Provides hemocompatible base layer while supporting antiproliferative drug delivery mechanisms.

Drug-eluting and bare metal stent platforms for coronary artery disease treatment and acute coronary syndrome management.

A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.